Product category:
Laboratory and scientific books and publishing
News Release from: Gower Publishing | Subject: Pharmaceutical Metrics (0 566 08676 X)
Edited by the Laboratorytalk Editorial
Team on 30 June 2006
Pharmaceutical metrics and Improving R+D
Book is a practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results
An earlier book, A Strategic Approach to Corporate Governance (Gower, 1999), examined corporate governance from a philosophical and 'big picture' standpoint This book digs deeper and explores the operational issues around corporate governance, giving examples of good practice
This article was originally published on Laboratorytalk on 15 Nov 2002 at 8.00am (UK)
Related stories
Volume on antiviral drugs
This book provides detailed information on drugs designed to control infection by viruses and retroviruses
Drugs: synonyms and properties
This reference, edited by world-renowned authority in drug design and chemical information and now in its second edition, has become one of the bibles of pharmaceutical esearch and application
It is a 'how to' book, which focuses on processes and practical issues.
The problem is that pharmaceutical businesses are complex.
Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all.
David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results.
And because metrics are about how to shape and develop your business, he explores how to deploy them organisation-wide and make sure that they are driving business improvement.
In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO.
This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R+D, supported by case studies of the techniques applied and tips for optimizing the system.
Pharmaceutical Metrics (0 566 08676 X) by David S Zuckerman has just been published by Gower.
It is available in hardback priced at £75.00.
• Gower Publishing: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
